TGA rejects acne drug downschedule bid

5 minute read


The therapeutic goods administration was inundated with submissions arguing that isotretinoin should continue to be initiated by a dermatologist only.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×